BANF1P3

Across TCGA pan-cancer cohorts, BANF1P3 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of BANF1P3’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where BANF1P3 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types BANF1P3 is over-expressed in tumor.

HNSC, COAD, and STAD are the cancer types where BANF1P3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in BANF1P3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	All	+0.631	<.001	11	view →
COAD	Female	All	+1.138	<.001	8	view →
STAD	All	II,III,IV	+0.762	<.001	8	view →
LIHC	All	All	+0.449	<.001	6	view →
BLCA	All	All	+0.446	.015	5	view →
LUSC	All	All	+0.413	<.001	5	view →
KIRP	All	II,III,IV	+0.532	.006	4	view →
BRCA	All	All	+0.430	<.001	4	view →
LUAD	All	All	+0.433	.004	3	view →
CHOL	All	All	+0.743	.001	2	view →
PRAD	All	All	+0.256	.031	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

BANF1P3–HNSC

Open the HNSC breakdown →